000 01673 a2200457 4500
005 20250517071827.0
264 0 _c20161213
008 201612s 0 0 eng d
022 _a1878-1705
024 7 _a10.1016/j.intimp.2015.12.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClark, Matthew P
245 0 0 _aAn aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
_h[electronic resource]
260 _bInternational immunopharmacology
_cFeb 2016
300 _a74-87 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnthracyclines
_xadministration & dosage
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aAutoimmunity
_xdrug effects
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aEncephalomyelitis, Autoimmune, Experimental
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppression Therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMitoxantrone
_xadministration & dosage
650 0 4 _aMultiple Sclerosis
_xdrug therapy
650 0 4 _aT-Box Domain Proteins
_xgenetics
650 0 4 _aTh1 Cells
_xdrug effects
650 0 4 _aTh2 Cells
_xdrug effects
650 0 4 _aT-bet Transcription Factor
700 1 _aLeaman, Douglas W
700 1 _aHazelhurst, Lori A
700 1 _aHwang, Eun S
700 1 _aQuinn, Anthony
773 0 _tInternational immunopharmacology
_gvol. 31
_gp. 74-87
856 4 0 _uhttps://doi.org/10.1016/j.intimp.2015.12.014
_zAvailable from publisher's website
999 _c25579957
_d25579957